The Science Journal of the American Association for Respiratory Care

2000 OPEN FORUM Abstracts

Verification of Flow-Inflating Manual Bag Resuscitator for Nitric Oxide Delivery

Miller CC, Fairbanks S, Miller JWR. University of British Columbia, Department of Experimental Medicine

Introduction: Abrupt interruption of inhaled nitric oxide (NO) delivery during mechanical ventilation is associated with a rapid deterioration in physiological status known as "rebound effect." Many routine procedures, such as bronchial hygiene maneuvers, changing out NO cylinders, during transports, or as a back-up during break down of NO delivery devices require that the patient be removed from the ventilator. During such times, a manual bag resuscitator is utilized to maintain ventilation. A system is needed to provide a stable NO dosage during these procedures. The purpose of this study is to evaluate the Pulmonox flow-inflating manual bag resuscitator (INObag). Method: The INObag was set-up according to the attached test set-up Figure 1. NO was provided from either one of two AeroNOx delivery devices or a Pulmonox back-up cylinder with a fix flow rate of 0.25 LPM. These sources were isolated from one another with a three-way stop-cock. A pressure gauge was attached to the pressure port and the INObag was attached to a test lung. The suggested sample site on the INObag was connected to a rapid response chemiluminescence NO analyzer (280 NOA, Sievers, USA) or one of two AeroNOx delivery devices (Pulmonox Medical Corp, Alberta, Canada). Additional sample locations included a site within the test lung and another within the reservoir of the INObag. A standard oxygen flow meter was attached to the INObag delivery line. NO and nitrogen dioxide (NO2) data were recorded from these various sites during testing conditions. A standard flow of 9-10 LPM oxygen was used with 0.25 LPM of NO to attain a desired delivery dosage of 20-25 parts per million (ppm). Ventilatory conditions were varied as follows: respiratory rate (RR) 0-150 bpm; peak inspiratory pressure (PIP) 0-40 cmH2O; positive end expiratory pressure (PEEP) of 0-5 cmH2O; and inspiratory wave pattern spiked and square. Also, a possible clinical condition was simulated to evaluate NO2 accumulation within the device between use if the device was not flushed out with a fresh gas flow as recommended by the manufacturer.

RR, PIP, PEEP and wave pattern had no significant effect on NO delivery (p>0.05) See Figures 2-4. There was good correlation between the chemiluminescence NO analyzer and both AeroNOx devices (r=0.86). In all simulated conditions during ventilation the NO2 remained below 0.2 ppm. The deadspace reservoir showed a NO2 concentration profile as shown in Figures 5-7. The peak NO2 at 80, 40 and 20 ppm NO and 100% oxygen over an hour period of time without flushing was 6.3 ppm (SD=1.74), 1.3 ppm (SD=0.42) and 0.2 ppm (SD=0.08) respectively. This was removed within 20 s with 10 LPM of fresh oxygen gas flow (Figure 8). Actual data is recorded ii Table 1. Conclusion: Use of the INObag for delivery of NO at 20-25 ppm under the clinical conditions tested does not pose any increased risk to patients receiving NO therapy during mechanical ventilation. We recommend that the system be flushed for 20 s before and after each use to ensure that NO2 is not allowed to build up within the systems dead space and reservoir.
Funding provided by Pulmonox Medical Corporation

You are here: » Past OPEN FORUM Abstracts » 2000 Abstracts » Verification of Flow-Inflating Manual Bag Resuscitator for Nitric Oxide Delivery